News & Updates
Inside Innovation
The latest news and advances from the world's most exciting life science cluster.

Sana Biotechnology names its first chief scientific officer
Sana Biotechnology recently announced the appointment of Dhaval Patel as its first chief scientific officer. Previously, Patel was a professor of medicine at both the

8 Contract Development and Manufacturing Companies to Watch
AGC Biologics, a Seattle-based leader in protein-based biologics and cell and gene therapies, is significantly advancing its operations. In June, the company completed a $200

Seattle biotech startup secures $11.2M to make drugs for ‘undruggable’ disease targets
Talus Bioscience, a Seattle-based biotech, recently announced it has raised $11.2 million in venture capital funding to advance its drug discovery program for treatment-resistant diseases.

WSU receives new $2.74M grant to support biotechnology training
Washington State University announced it has received a $2.74 million T32 training grant from the National Institute of Health to expand its innovative NIH Protein

Seattle biotech company doubles space with new lease in Interbay
Curi Bio, a Seattle-based biotech company, has significantly expanded its operations with a new 13,942-square-foot lease in the Interbay neighborhood of Seattle. Eric Swanson, vice

AI antibody generator Absci inks cancer collaboration with Memorial Sloan Kettering
Absci, a generative AI drug creation company headquartered in Vancouver, Washington, announced its partnership with Memorial Sloan Kettering Cancer Center to co-develop up to six

Biden grants UW-led team $21M to develop cancer surgery technology
A research team led by the University of Washington will receive up to $21.2 million as part of Biden’s Cancer Moonshot initiative to reduce cancer

Inside the Seattle labs of Xaira, the AI-powered startup launched with $1B from investors
Xaira Therapeutics – a spinout from the University of Washington’s Institute for Protein Design (IPD) – merges AI with science to create generative models for

Sana CEO outlines growth plans after opening Bothell facility
Headquartered in Seattle, Sana Biotechnology opened its new 80,000 square-foot manufacturing facility in Bothell, Washington, which will house Sana’s proprietary cancer drug program. Sana utilizes

AGC Biologics’ Seattle Site Achieves Successful Multi-Product Inspection by U.S. Food and Drug Administration for Biologics License Applications
AGC Biologics, a Seattle-based biomanufacturer, announced that its Seattle campus achieved a new milestone for regulatory compliance in partnership with the Food and Drug Administration

Protein design startup Outpace lands $144M to test treatments targeting solid tumors
Outpace Bio, a Seattle-based startup using AI to design proteins for cancer therapies targeting solid tumors, has secured $144 million in new funding from investors.

UW lands $50M from National Science Foundation to lead new center for research security
The University of Washington has been awarded a $50 million grant from the National Science Foundation to spearhead the Safeguarding the Entire Community of the
